Oxford-AstraZeneca Vaccine Effective Against Severe Covid-19, New Trial in US Confirms
3 years, 9 months ago

Oxford-AstraZeneca Vaccine Effective Against Severe Covid-19, New Trial in US Confirms

News 18  

A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent effectiveness in stopping severe disease and hospitalisation, the biotech firm said on Monday. The vaccine’s efficacy was consistent across ethnicity and age, and in participants aged 65 years and over, its effectiveness was 80 per cent. In the trial, which recruited over 32,000 volunteers across all age groups, the participants received either two standard doses of the Oxford-AstraZeneca vaccine or a placebo vaccine, at a four-week interval. In many different countries and across age groups, the vaccine is providing a high level of protection against COVID-19 and we hope this will lead to even more widespread use of the vaccine in the global attempts to bring the pandemic to an end, said Sarah Gilbert, Professor of Vaccinology, and co-designer of the ChAdOx1 nCov-19 coronavirus vaccine named AZD1222 by AstraZeneca.

Trial Cent Virus Vaccine Oxford Participants Oxford University Efficacy Dsmb  covid19  confirms  trial  vaccine  severe  cent  participants  efficacy  effective  virus  university  oxfordastrazeneca  results

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
8 months ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
8 months ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims
1 year, 1 month ago

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

The Telegraph  

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed. Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”. ‘Side effects ignored’ Anthony …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 2 months ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 2 months ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 2 months ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 8 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

'New plant-based COVID-19 vaccine 70% effective against variants'
2 years, 8 months ago

'New plant-based COVID-19 vaccine 70% effective against variants'

Firstpost  

The vaccine developed by researchers at Canadian biotechnology company Medicago contains coronavirus-like particles produced in plants which are combined with an adjuvant that helps vaccines work better Toronto: A new plant-based COVID-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 8 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

New COVID-19 data shows unvaccinated have 'triple' the risk of death compared with fully jabbed
2 years, 8 months ago

New COVID-19 data shows unvaccinated have 'triple' the risk of death compared with fully jabbed

ABC  

South Australian health authorities have released COVID vaccination statistics showing people who are unvaccinated are more than three times as likely to die from the virus than those who've had three doses. Key points: Unvaccinated people have "triple the chance of dying" of those with three or more jabs, SA's health chief said Nicola Spurrier issued the warning ahead of …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Covid-19 booster shots are a must
2 years, 10 months ago

Covid-19 booster shots are a must

Hindustan Times  

India’s continued reluctance to widen the eligibility for booster shots of Covid-19 vaccines is inexplicable. PREMIUM Given the level of vaccination — 77.9% of Indians aged 15 or above have been fully vaccinated, and 17.1% are partly vaccinated — and the fact that Omicron infected just about everybody in the cities, it is unlikely India will ever see that kind …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 11 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
3 years ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

Booster dose of six Covid vaccines safe, increases immunity: Lancet study
3 years, 1 month ago

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Deccan Chronicle  

New Delhi: Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines, according to a study published in The Lancet journal. Two doses of AstraZeneca and Pfizer vaccines have shown 79 per cent and 90 per cent protection, respectively, against hospitalisation and death after six …

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave
3 years, 1 month ago

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The Covishield vaccine was effective …

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm
3 years, 1 month ago

AstraZeneca vaccine could be key reason why Britain is weathering the new Covid storm

The Telegraph  

It is the key question puzzling scientists and commentators – how is Britain managing to weather the latest deadly Covid storm while our European neighbours' defences are crumbling? He suggested that the durability of T-cells from the Oxford/AstraZeneca jab could be keeping older people safer than those on the continent, preventing hospitilisations and deaths even though virus cases are still …

AstraZeneca age group has fewer antibodies against corona, blood bank finds
3 years, 2 months ago

AstraZeneca age group has fewer antibodies against corona, blood bank finds

Dutch News  

People in their early sixties, the age group that was given the AstraZeneca vaccine, have fewer antibodies against coronavirus than other vaccinated groups, according to national blood bank Sanquin. A study of around 1,400 samples from blood donors found that people in the 18 to 25 age group had on average eight times as many antibodies as people aged 61 …

AstraZeneca seems to be losing efficacy fastest: blood bank
3 years, 2 months ago

AstraZeneca seems to be losing efficacy fastest: blood bank

NL Times  

Vaccinated people between the ages of 61 and 65 have a lot fewer antibodies against the coronavirus than vaccinated people in other age groups. According to Zaaijer, the very youngest donors, aged 18 to 25, have on average almost eight times more antibodies in their blood than people in the group aged 61 to 65. An older age group, aged …

Mix-and-match vaccines highly effective against COVID-19: Lancet study
3 years, 2 months ago

Mix-and-match vaccines highly effective against COVID-19: Lancet study

Deccan Chronicle  

London: People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study in Sweden. "However, our study shows a greater risk reduction for people who received an mRNA vaccine after having received …

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial
3 years, 3 months ago

AstraZeneca Covid-19 vaccine shows 74% efficacy in large US trial

India Today  

AstraZeneca Plc's Covid-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people aged 65 and older, according to long-awaited results of the company's US clinical trial published on Wednesday. Overall efficacy of 74% was lower than the interim 79% figure reported by the British drugmaker in March, a result AstraZeneca revised days later …

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?
3 years, 3 months ago

How effective are the Pfizer, Moderna and AstraZeneca COVID-19 vaccines?

ABC  

When COVID-19 vaccines were being developed, manufacturers had to hit an efficacy rate of 50 per cent before their jabs could get approval. Australian National Centre for Immunisation Research and Surveillance director Kristine Macartney said it was important that people do not just look at one study or compare one study with another because, often, "the studies are done in …

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
3 years, 4 months ago

COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary

Firstpost  

Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant London: Booster shots to extend the protection of COVID-19 vaccines may be unnecessary for many people, a leading scientist behind the AstraZeneca vaccine said on Friday. Oxford University Professor Sarah Gilbert told The Telegraph newspaper that …

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting
3 years, 4 months ago

Over 60 and waiting for the Pfizer COVID vaccine? You could die waiting

ABC  

The nation's peak medical body has issued a stark warning: if you're over 60 and are hoping to get the Pfizer COVID-19 jab, you could die waiting. Key points: More than half a million Australians aged between 60 and 69 haven't received a single COVID-19 vaccine dose The Prime Minister has penned a letter urging Australians over 60 to get …

Covid vaccines effective at reducing severe illness, hospitalisation: Lancet study
3 years, 4 months ago

Covid vaccines effective at reducing severe illness, hospitalisation: Lancet study

Deccan Chronicle  

London: People infected with the SARS-CoV-2 virus after receiving one or two COVID-19 vaccine doses have significantly lower chance of severe disease or hospitalisation than unvaccinated individuals, according to a large-scale study published in The Lancet Infectious Diseases journal on Tuesday. Researchers also found that the odds of experiencing long COVID -- illness lasting 28 days or more after a …

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study
3 years, 4 months ago

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study

Firstpost  

The study estimated that for 10 million people who received the AstraZeneca jab, there were seven additional cases, compared to 20 in people with Covid infection. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the UK recommending that healthy people under 40 get alternative vaccines. …

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows
3 years, 4 months ago

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows

LA Times  

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer plant in Portage, Mich. COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with the AstraZeneca or Pfizer shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will …

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug
3 years, 4 months ago

AstraZeneca announces positive results from clinical trial of COVID-19 prevention drug

Firstpost  

This trial has 5,197 participants who had not been exposed and showed a 77-percent reduced risk of developing symptomatic disease with no severe cases recorded. Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for Covid-19 symptoms. A new trial of 5,197 participants who had not been exposed showed a 77-percent reduced risk of developing …

Pfizer COVID-19 jab declines faster than AstraZeneca: study
3 years, 4 months ago

Pfizer COVID-19 jab declines faster than AstraZeneca: study

The Hindu  

The effectiveness of the Pfizer-BioNTech vaccine against COVID-19 declines faster than that of the AstraZeneca jab, according to a new study published on August 19. "Two doses of Pfizer-BioNTech have greater initial effectiveness against new COVID-19 infections, but this declines faster compared with two doses of Oxford-AstraZeneca," researchers at Oxford University said. It found that "the dynamics of immunity following …

COVID vaccine efficacy wanes, but jabs offer protection: Study
3 years, 4 months ago

COVID vaccine efficacy wanes, but jabs offer protection: Study

Al Jazeera  

Oxford University researchers say efficacy of Pfizer, AstraZeneca weakens 90 days after second dose, but both ‘still doing really well against Delta’ strain. The efficacy of two widely used coronavirus vaccines against the Delta variant weakens within three months of inoculation, but the jabs remain the most effective way to ensure protection against the strain, Oxford University researchers have found. …

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available
3 years, 4 months ago

Surge in COVID jabs for young people in NSW and Victoria as vaccines become more available

ABC  

Young Australians in locked-down cities are rolling up their sleeves in massive numbers to protect themselves with the AstraZeneca vaccine. Unvaccinated younger workers who cannot work from home are continuing to circulate the virus in Sydney, and the NSW government is hoping higher vaccination rates will put downward pressure on the infection curve, as well as reduce the number of …

Young people explain why they are seeking out COVID-19 jabs
3 years, 5 months ago

Young people explain why they are seeking out COVID-19 jabs

ABC  

Many months after Australians first started getting coronavirus vaccines, incremental changes are enabling more young people to access the jabs. Young people getting their first dose at the vaccine hub at Carlton's Royal Exhibition Building shared some of their motivations, thoughts and hopes as they took the crucial step. "Since they allowed AstraZeneca into the state facilities I think more …

UK to expand Covid-19 vaccination programme to 16 and 17-year-olds
3 years, 5 months ago

UK to expand Covid-19 vaccination programme to 16 and 17-year-olds

India Today  

Britain's health service will expand its Covid-19 vaccination programme to everyone aged 16 and over, from the current 18 and over, after formal scientific advice in favour of younger age cohorts on Wednesday. "Today’s advice from the independent Joint Committee on Vaccination and Immunisation means more young people aged 16 and over can benefit from Covid-19 vaccines. READ: Mixed AstraZeneca-Pfizer …

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta
3 years, 5 months ago

Sydney's COVID outbreak means more people are getting AstraZeneca's vaccine — here's how it can help against Delta

ABC  

Back in April, the Prime Minister stood up at a late-night press conference and announced the Pfizer vaccine would be preferred over AstraZeneca for most people under 50. Key points: Two doses of AstraZeneca is 92 per cent effective against hospitalisation from the Delta variant, a UK study found Two doses of AstraZeneca is 92 per cent effective against hospitalisation …

ATAGI urges all adult Sydneysiders to 'strongly consider' the AstraZeneca vaccine amid NSW COVID outbreak
3 years, 5 months ago

ATAGI urges all adult Sydneysiders to 'strongly consider' the AstraZeneca vaccine amid NSW COVID outbreak

ABC  

All adults in Greater Sydney should “strongly consider” getting vaccinated with any available vaccine, including AstraZeneca, Australia's expert vaccines body says. Key points: ATAGI says it updated the advice to reflect the worsening COVID situation in Sydney Deputy Chief Medical Officer Michael Kidd says there is evidence the Delta strain has a more serious impact on younger people The vaccine …

TGA links deaths of 44yo Tasmanian man and 48yo Victorian woman to AstraZeneca vaccine
3 years, 5 months ago

TGA links deaths of 44yo Tasmanian man and 48yo Victorian woman to AstraZeneca vaccine

ABC  

The Therapeutic Goods Administration has been notified of two more fatal cases of the rare blood clotting disorder related to AstraZeneca. Key points: These are the fifth and sixth deaths linked to the first dose of the AstraZeneca vaccine from 6.1 million doses, according to the TGA These are the fifth and sixth deaths linked to the first dose of …

ATAGI advice on AstraZeneca COVID-19 vaccine remains unchanged for under 60s
3 years, 5 months ago

ATAGI advice on AstraZeneca COVID-19 vaccine remains unchanged for under 60s

ABC  

The expert panel advising on Australia's COVID-19 vaccine rollout has not changed its advice limiting AstraZeneca vaccines to people over 60. Key points: ATAGI, the government's expert panel on vaccines, meets each week to discuss the government's response to the pandemic; The panel did not change its advice limiting AstraZeneca to people over 60 Prime Minister Scott Morrison indicated the …

AstraZeneca vaccine for under-40s. This is what health experts, politicians and ATAGI have said
3 years, 6 months ago

AstraZeneca vaccine for under-40s. This is what health experts, politicians and ATAGI have said

ABC  

Allowing under-40s to go and chat to their doctors to potentially get the AstraZeneca jab has led to a raft of comments from politicians and health experts over the last couple of days. Back to top Prime Minister Scott Morrison At a press conference after an emergency National Cabinet meeting on Monday, the Prime Minister said the ATAGI advice did …

Oxford/AstraZeneca Vaccine makers get standing ovation at Wimbledon | WATCH
3 years, 6 months ago

Oxford/AstraZeneca Vaccine makers get standing ovation at Wimbledon | WATCH

India TV News  

Tennis fans gave the creators of the Oxford-AstraZeneca vaccine a standing ovation at Wimbledon's Centre Court on Monday, the first day of the tournament Dame Sarah Gilbert and her colleague Sir Andrew Pollard, both of whom helped develop the vaccine, were there, The Guardian reported, as key workers and other "inspirational individuals" from the pandemic were invited to the match. …

Oxford study says mixing COVID-19 vaccines gives good protection
3 years, 6 months ago

Oxford study says mixing COVID-19 vaccines gives good protection

Deccan Chronicle  

London: Amid the global shortage of the COVID-19 vaccines, a study conducted by Oxford University has found out that alternating doses of the AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against the coronavirus. "The Com-COV study has evaluated 'mix and match' combinations of the Oxford and Pfizer vaccines to see to what extent these vaccines can be used interchangeably, …

Who can get the AstraZeneca COVID-19 vaccine in Australia and what are the risks?
3 years, 6 months ago

Who can get the AstraZeneca COVID-19 vaccine in Australia and what are the risks?

ABC  

Australians are facing tighter restrictions and days of lockdown as the highly contagious Delta variant of COVID-19 sweeps parts of the nation. "If you wish to get the AstraZeneca vaccine, then we would encourage you to go and have that discussion with your GP," Mr Morrison said. So, anyone over age 18 who has been eligible to get a COVID-19 …

Ten month gap between AstraZeneca doses sees highest antibody boost: Oxford study
3 years, 6 months ago

Ten month gap between AstraZeneca doses sees highest antibody boost: Oxford study

The Hindu  

Two doses of the AstraZeneca vaccine administered 44-45 weeks apart generated nearly four times the level of antibodies than when the doses were given 8-12 weeks apart, says a report by the Oxford Vaccine Group, the developers of the vaccine, on Monday. Antibody levels remained elevated for nearly a year and a third booster dose of the vaccine, given to …

AstraZeneca tests Covid booster shots against Beta-variant
3 years, 6 months ago

AstraZeneca tests Covid booster shots against Beta-variant

India TV News  

British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against Beta Covid variant. The booster shot, named AZD2816, will be administered to individuals who have previously been fully vaccinated with two doses of AstraZeneca vaccine/Vaxzervia or an mRNA vaccine, at least three months after their last injection. AZD2816 has been …

Discover Related